Studies have shown that FOXN3 suppresses the mRNA and protein expression of E2F5 by inhibiting the promoter activity of potential oncogene E2F5, thereby inhibiting the proliferation of HCC cells in vitro and in vivo (43). This evidence concerns the gene E2F5 and hepatocellular carcinoma.